would not be surprised if fund managers are doing there homework already and seeing what other products such as Autism insomnia chronic pain then pre clinical tests such as pancreatic cancer brain cancer enhanced distillate capture and dissolution matrix technology breast cancer and nuerological disorders major players may just look at ZLD in a different more favourable light attracting some $$$$$
